Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
13,544
archived clinical trials in
Ovarian Cancer

Paclitaxel in Treating Patients With Ovarian Stromal Cancer
Phase II Study of Paclitaxel for Ovarian Stromal Tumors as Second-Line Therapy
Status: Enrolling
Updated:  8/23/2017
Women's Cancer Center of Nevada
mi
from
Las Vegas, NV
Paclitaxel in Treating Patients With Ovarian Stromal Cancer
Phase II Study of Paclitaxel for Ovarian Stromal Tumors as Second-Line Therapy
Status: Enrolling
Updated: 8/23/2017
Women's Cancer Center of Nevada
mi
from
Las Vegas, NV
Click here to add this to my saved trials
Paclitaxel in Treating Patients With Ovarian Stromal Cancer
Phase II Study of Paclitaxel for Ovarian Stromal Tumors as Second-Line Therapy
Status: Enrolling
Updated:  8/23/2017
Cooper Hospital University Medical Center
mi
from
Camden, NJ
Paclitaxel in Treating Patients With Ovarian Stromal Cancer
Phase II Study of Paclitaxel for Ovarian Stromal Tumors as Second-Line Therapy
Status: Enrolling
Updated: 8/23/2017
Cooper Hospital University Medical Center
mi
from
Camden, NJ
Click here to add this to my saved trials
Paclitaxel in Treating Patients With Ovarian Stromal Cancer
Phase II Study of Paclitaxel for Ovarian Stromal Tumors as Second-Line Therapy
Status: Enrolling
Updated:  8/23/2017
State University of New York - Downstate Medical Center
mi
from
Brooklyn, NY
Paclitaxel in Treating Patients With Ovarian Stromal Cancer
Phase II Study of Paclitaxel for Ovarian Stromal Tumors as Second-Line Therapy
Status: Enrolling
Updated: 8/23/2017
State University of New York - Downstate Medical Center
mi
from
Brooklyn, NY
Click here to add this to my saved trials
Paclitaxel in Treating Patients With Ovarian Stromal Cancer
Phase II Study of Paclitaxel for Ovarian Stromal Tumors as Second-Line Therapy
Status: Enrolling
Updated:  8/23/2017
UNC Lineberger Comprehensive Cancer Center
mi
from
Chapel Hill, NC
Paclitaxel in Treating Patients With Ovarian Stromal Cancer
Phase II Study of Paclitaxel for Ovarian Stromal Tumors as Second-Line Therapy
Status: Enrolling
Updated: 8/23/2017
UNC Lineberger Comprehensive Cancer Center
mi
from
Chapel Hill, NC
Click here to add this to my saved trials
Paclitaxel in Treating Patients With Ovarian Stromal Cancer
Phase II Study of Paclitaxel for Ovarian Stromal Tumors as Second-Line Therapy
Status: Enrolling
Updated:  8/23/2017
Carolinas Medical Center / Levine Cancer Institute
mi
from
Charlotte, NC
Paclitaxel in Treating Patients With Ovarian Stromal Cancer
Phase II Study of Paclitaxel for Ovarian Stromal Tumors as Second-Line Therapy
Status: Enrolling
Updated: 8/23/2017
Carolinas Medical Center / Levine Cancer Institute
mi
from
Charlotte, NC
Click here to add this to my saved trials
Paclitaxel in Treating Patients With Ovarian Stromal Cancer
Phase II Study of Paclitaxel for Ovarian Stromal Tumors as Second-Line Therapy
Status: Enrolling
Updated:  8/23/2017
Duke Univ Med Ctr
mi
from
Durham, NC
Paclitaxel in Treating Patients With Ovarian Stromal Cancer
Phase II Study of Paclitaxel for Ovarian Stromal Tumors as Second-Line Therapy
Status: Enrolling
Updated: 8/23/2017
Duke Univ Med Ctr
mi
from
Durham, NC
Click here to add this to my saved trials
Paclitaxel in Treating Patients With Ovarian Stromal Cancer
Phase II Study of Paclitaxel for Ovarian Stromal Tumors as Second-Line Therapy
Status: Enrolling
Updated:  8/23/2017
Brookview Research Incorporated
mi
from
Winston-Salem, NC
Paclitaxel in Treating Patients With Ovarian Stromal Cancer
Phase II Study of Paclitaxel for Ovarian Stromal Tumors as Second-Line Therapy
Status: Enrolling
Updated: 8/23/2017
Brookview Research Incorporated
mi
from
Winston-Salem, NC
Click here to add this to my saved trials
Paclitaxel in Treating Patients With Ovarian Stromal Cancer
Phase II Study of Paclitaxel for Ovarian Stromal Tumors as Second-Line Therapy
Status: Enrolling
Updated:  8/23/2017
Novant Health Forsyth Medical Center
mi
from
Winston-Salem, NC
Paclitaxel in Treating Patients With Ovarian Stromal Cancer
Phase II Study of Paclitaxel for Ovarian Stromal Tumors as Second-Line Therapy
Status: Enrolling
Updated: 8/23/2017
Novant Health Forsyth Medical Center
mi
from
Winston-Salem, NC
Click here to add this to my saved trials
Paclitaxel in Treating Patients With Ovarian Stromal Cancer
Phase II Study of Paclitaxel for Ovarian Stromal Tumors as Second-Line Therapy
Status: Enrolling
Updated:  8/23/2017
Novant Health Oncology Specialists
mi
from
Winston-Salem, NC
Paclitaxel in Treating Patients With Ovarian Stromal Cancer
Phase II Study of Paclitaxel for Ovarian Stromal Tumors as Second-Line Therapy
Status: Enrolling
Updated: 8/23/2017
Novant Health Oncology Specialists
mi
from
Winston-Salem, NC
Click here to add this to my saved trials
Paclitaxel in Treating Patients With Ovarian Stromal Cancer
Phase II Study of Paclitaxel for Ovarian Stromal Tumors as Second-Line Therapy
Status: Enrolling
Updated:  8/23/2017
Wake Forest University Health Sciences
mi
from
Winston-Salem, NC
Paclitaxel in Treating Patients With Ovarian Stromal Cancer
Phase II Study of Paclitaxel for Ovarian Stromal Tumors as Second-Line Therapy
Status: Enrolling
Updated: 8/23/2017
Wake Forest University Health Sciences
mi
from
Winston-Salem, NC
Click here to add this to my saved trials
Paclitaxel in Treating Patients With Ovarian Stromal Cancer
Phase II Study of Paclitaxel for Ovarian Stromal Tumors as Second-Line Therapy
Status: Enrolling
Updated:  8/23/2017
Aultman Health Foundation
mi
from
Canton, OH
Paclitaxel in Treating Patients With Ovarian Stromal Cancer
Phase II Study of Paclitaxel for Ovarian Stromal Tumors as Second-Line Therapy
Status: Enrolling
Updated: 8/23/2017
Aultman Health Foundation
mi
from
Canton, OH
Click here to add this to my saved trials
Paclitaxel in Treating Patients With Ovarian Stromal Cancer
Phase II Study of Paclitaxel for Ovarian Stromal Tumors as Second-Line Therapy
Status: Enrolling
Updated:  8/23/2017
Case Western Reserve Univ
mi
from
Cleveland, OH
Paclitaxel in Treating Patients With Ovarian Stromal Cancer
Phase II Study of Paclitaxel for Ovarian Stromal Tumors as Second-Line Therapy
Status: Enrolling
Updated: 8/23/2017
Case Western Reserve Univ
mi
from
Cleveland, OH
Click here to add this to my saved trials
Paclitaxel in Treating Patients With Ovarian Stromal Cancer
Phase II Study of Paclitaxel for Ovarian Stromal Tumors as Second-Line Therapy
Status: Enrolling
Updated:  8/23/2017
MetroHealth Med Ctr
mi
from
Cleveland, OH
Paclitaxel in Treating Patients With Ovarian Stromal Cancer
Phase II Study of Paclitaxel for Ovarian Stromal Tumors as Second-Line Therapy
Status: Enrolling
Updated: 8/23/2017
MetroHealth Med Ctr
mi
from
Cleveland, OH
Click here to add this to my saved trials
Paclitaxel in Treating Patients With Ovarian Stromal Cancer
Phase II Study of Paclitaxel for Ovarian Stromal Tumors as Second-Line Therapy
Status: Enrolling
Updated:  8/23/2017
Cleveland Clinic Foundation
mi
from
Cleveland, OH
Paclitaxel in Treating Patients With Ovarian Stromal Cancer
Phase II Study of Paclitaxel for Ovarian Stromal Tumors as Second-Line Therapy
Status: Enrolling
Updated: 8/23/2017
Cleveland Clinic Foundation
mi
from
Cleveland, OH
Click here to add this to my saved trials
Paclitaxel in Treating Patients With Ovarian Stromal Cancer
Phase II Study of Paclitaxel for Ovarian Stromal Tumors as Second-Line Therapy
Status: Enrolling
Updated:  8/23/2017
Ohio State University Comprehensive Cancer Center
mi
from
Columbus, OH
Paclitaxel in Treating Patients With Ovarian Stromal Cancer
Phase II Study of Paclitaxel for Ovarian Stromal Tumors as Second-Line Therapy
Status: Enrolling
Updated: 8/23/2017
Ohio State University Comprehensive Cancer Center
mi
from
Columbus, OH
Click here to add this to my saved trials
Paclitaxel in Treating Patients With Ovarian Stromal Cancer
Phase II Study of Paclitaxel for Ovarian Stromal Tumors as Second-Line Therapy
Status: Enrolling
Updated:  8/23/2017
Riverside Methodist Hospital
mi
from
Columbus, OH
Paclitaxel in Treating Patients With Ovarian Stromal Cancer
Phase II Study of Paclitaxel for Ovarian Stromal Tumors as Second-Line Therapy
Status: Enrolling
Updated: 8/23/2017
Riverside Methodist Hospital
mi
from
Columbus, OH
Click here to add this to my saved trials
Paclitaxel in Treating Patients With Ovarian Stromal Cancer
Phase II Study of Paclitaxel for Ovarian Stromal Tumors as Second-Line Therapy
Status: Enrolling
Updated:  8/23/2017
Mount Carmel Health Center West
mi
from
Columbus, OH
Paclitaxel in Treating Patients With Ovarian Stromal Cancer
Phase II Study of Paclitaxel for Ovarian Stromal Tumors as Second-Line Therapy
Status: Enrolling
Updated: 8/23/2017
Mount Carmel Health Center West
mi
from
Columbus, OH
Click here to add this to my saved trials
Paclitaxel in Treating Patients With Ovarian Stromal Cancer
Phase II Study of Paclitaxel for Ovarian Stromal Tumors as Second-Line Therapy
Status: Enrolling
Updated:  8/23/2017
Kettering Medical Center
mi
from
Kettering, OH
Paclitaxel in Treating Patients With Ovarian Stromal Cancer
Phase II Study of Paclitaxel for Ovarian Stromal Tumors as Second-Line Therapy
Status: Enrolling
Updated: 8/23/2017
Kettering Medical Center
mi
from
Kettering, OH
Click here to add this to my saved trials
Paclitaxel in Treating Patients With Ovarian Stromal Cancer
Phase II Study of Paclitaxel for Ovarian Stromal Tumors as Second-Line Therapy
Status: Enrolling
Updated:  8/23/2017
Hillcrest Hospital Cancer Center
mi
from
Mayfield Heights, OH
Paclitaxel in Treating Patients With Ovarian Stromal Cancer
Phase II Study of Paclitaxel for Ovarian Stromal Tumors as Second-Line Therapy
Status: Enrolling
Updated: 8/23/2017
Hillcrest Hospital Cancer Center
mi
from
Mayfield Heights, OH
Click here to add this to my saved trials
Paclitaxel in Treating Patients With Ovarian Stromal Cancer
Phase II Study of Paclitaxel for Ovarian Stromal Tumors as Second-Line Therapy
Status: Enrolling
Updated:  8/23/2017
Lake University Ireland Cancer Center
mi
from
Mentor, OH
Paclitaxel in Treating Patients With Ovarian Stromal Cancer
Phase II Study of Paclitaxel for Ovarian Stromal Tumors as Second-Line Therapy
Status: Enrolling
Updated: 8/23/2017
Lake University Ireland Cancer Center
mi
from
Mentor, OH
Click here to add this to my saved trials
Paclitaxel in Treating Patients With Ovarian Stromal Cancer
Phase II Study of Paclitaxel for Ovarian Stromal Tumors as Second-Line Therapy
Status: Enrolling
Updated:  8/23/2017
University of Oklahoma Health Sciences Center
mi
from
Oklahoma City, OK
Paclitaxel in Treating Patients With Ovarian Stromal Cancer
Phase II Study of Paclitaxel for Ovarian Stromal Tumors as Second-Line Therapy
Status: Enrolling
Updated: 8/23/2017
University of Oklahoma Health Sciences Center
mi
from
Oklahoma City, OK
Click here to add this to my saved trials
Paclitaxel in Treating Patients With Ovarian Stromal Cancer
Phase II Study of Paclitaxel for Ovarian Stromal Tumors as Second-Line Therapy
Status: Enrolling
Updated:  8/23/2017
Oklahoma Cancer Specialists and Research Institute-Tulsa
mi
from
Tulsa, OK
Paclitaxel in Treating Patients With Ovarian Stromal Cancer
Phase II Study of Paclitaxel for Ovarian Stromal Tumors as Second-Line Therapy
Status: Enrolling
Updated: 8/23/2017
Oklahoma Cancer Specialists and Research Institute-Tulsa
mi
from
Tulsa, OK
Click here to add this to my saved trials
Paclitaxel in Treating Patients With Ovarian Stromal Cancer
Phase II Study of Paclitaxel for Ovarian Stromal Tumors as Second-Line Therapy
Status: Enrolling
Updated:  8/23/2017
Abington Memorial Hospital
mi
from
Abington, PA
Paclitaxel in Treating Patients With Ovarian Stromal Cancer
Phase II Study of Paclitaxel for Ovarian Stromal Tumors as Second-Line Therapy
Status: Enrolling
Updated: 8/23/2017
Abington Memorial Hospital
mi
from
Abington, PA
Click here to add this to my saved trials
Paclitaxel in Treating Patients With Ovarian Stromal Cancer
Phase II Study of Paclitaxel for Ovarian Stromal Tumors as Second-Line Therapy
Status: Enrolling
Updated:  8/23/2017
Lehigh Valley Hospital-Cedar Crest
mi
from
Allentown, PA
Paclitaxel in Treating Patients With Ovarian Stromal Cancer
Phase II Study of Paclitaxel for Ovarian Stromal Tumors as Second-Line Therapy
Status: Enrolling
Updated: 8/23/2017
Lehigh Valley Hospital-Cedar Crest
mi
from
Allentown, PA
Click here to add this to my saved trials
Paclitaxel in Treating Patients With Ovarian Stromal Cancer
Phase II Study of Paclitaxel for Ovarian Stromal Tumors as Second-Line Therapy
Status: Enrolling
Updated:  8/23/2017
Temple University Hospital
mi
from
Philadelphia, PA
Paclitaxel in Treating Patients With Ovarian Stromal Cancer
Phase II Study of Paclitaxel for Ovarian Stromal Tumors as Second-Line Therapy
Status: Enrolling
Updated: 8/23/2017
Temple University Hospital
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Paclitaxel in Treating Patients With Ovarian Stromal Cancer
Phase II Study of Paclitaxel for Ovarian Stromal Tumors as Second-Line Therapy
Status: Enrolling
Updated:  8/23/2017
Southeast Gynecologic Oncology Associates
mi
from
Knoxville, TN
Paclitaxel in Treating Patients With Ovarian Stromal Cancer
Phase II Study of Paclitaxel for Ovarian Stromal Tumors as Second-Line Therapy
Status: Enrolling
Updated: 8/23/2017
Southeast Gynecologic Oncology Associates
mi
from
Knoxville, TN
Click here to add this to my saved trials
Paclitaxel in Treating Patients With Ovarian Stromal Cancer
Phase II Study of Paclitaxel for Ovarian Stromal Tumors as Second-Line Therapy
Status: Enrolling
Updated:  8/23/2017
University of Tennessee Health Science Center
mi
from
Memphis, TN
Paclitaxel in Treating Patients With Ovarian Stromal Cancer
Phase II Study of Paclitaxel for Ovarian Stromal Tumors as Second-Line Therapy
Status: Enrolling
Updated: 8/23/2017
University of Tennessee Health Science Center
mi
from
Memphis, TN
Click here to add this to my saved trials
Paclitaxel in Treating Patients With Ovarian Stromal Cancer
Phase II Study of Paclitaxel for Ovarian Stromal Tumors as Second-Line Therapy
Status: Enrolling
Updated:  8/23/2017
Brooke Army Medical Center
mi
from
Fort Sam Houston, TX
Paclitaxel in Treating Patients With Ovarian Stromal Cancer
Phase II Study of Paclitaxel for Ovarian Stromal Tumors as Second-Line Therapy
Status: Enrolling
Updated: 8/23/2017
Brooke Army Medical Center
mi
from
Fort Sam Houston, TX
Click here to add this to my saved trials
Paclitaxel in Treating Patients With Ovarian Stromal Cancer
Phase II Study of Paclitaxel for Ovarian Stromal Tumors as Second-Line Therapy
Status: Enrolling
Updated:  8/23/2017
MultiCare Auburn Medical Center
mi
from
Auburn, WA
Paclitaxel in Treating Patients With Ovarian Stromal Cancer
Phase II Study of Paclitaxel for Ovarian Stromal Tumors as Second-Line Therapy
Status: Enrolling
Updated: 8/23/2017
MultiCare Auburn Medical Center
mi
from
Auburn, WA
Click here to add this to my saved trials
Paclitaxel in Treating Patients With Ovarian Stromal Cancer
Phase II Study of Paclitaxel for Ovarian Stromal Tumors as Second-Line Therapy
Status: Enrolling
Updated:  8/23/2017
Providence Regional Cancer System-Centralia
mi
from
Centralia, WA
Paclitaxel in Treating Patients With Ovarian Stromal Cancer
Phase II Study of Paclitaxel for Ovarian Stromal Tumors as Second-Line Therapy
Status: Enrolling
Updated: 8/23/2017
Providence Regional Cancer System-Centralia
mi
from
Centralia, WA
Click here to add this to my saved trials
Paclitaxel in Treating Patients With Ovarian Stromal Cancer
Phase II Study of Paclitaxel for Ovarian Stromal Tumors as Second-Line Therapy
Status: Enrolling
Updated:  8/23/2017
Saint Francis Hospital
mi
from
Federal Way, WA
Paclitaxel in Treating Patients With Ovarian Stromal Cancer
Phase II Study of Paclitaxel for Ovarian Stromal Tumors as Second-Line Therapy
Status: Enrolling
Updated: 8/23/2017
Saint Francis Hospital
mi
from
Federal Way, WA
Click here to add this to my saved trials
Paclitaxel in Treating Patients With Ovarian Stromal Cancer
Phase II Study of Paclitaxel for Ovarian Stromal Tumors as Second-Line Therapy
Status: Enrolling
Updated:  8/23/2017
Saint Clare Hospital
mi
from
Lakewood, WA
Paclitaxel in Treating Patients With Ovarian Stromal Cancer
Phase II Study of Paclitaxel for Ovarian Stromal Tumors as Second-Line Therapy
Status: Enrolling
Updated: 8/23/2017
Saint Clare Hospital
mi
from
Lakewood, WA
Click here to add this to my saved trials
Paclitaxel in Treating Patients With Ovarian Stromal Cancer
Phase II Study of Paclitaxel for Ovarian Stromal Tumors as Second-Line Therapy
Status: Enrolling
Updated:  8/23/2017
Providence - Saint Peter Hospital
mi
from
Olympia, WA
Paclitaxel in Treating Patients With Ovarian Stromal Cancer
Phase II Study of Paclitaxel for Ovarian Stromal Tumors as Second-Line Therapy
Status: Enrolling
Updated: 8/23/2017
Providence - Saint Peter Hospital
mi
from
Olympia, WA
Click here to add this to my saved trials
Paclitaxel in Treating Patients With Ovarian Stromal Cancer
Phase II Study of Paclitaxel for Ovarian Stromal Tumors as Second-Line Therapy
Status: Enrolling
Updated:  8/23/2017
Capital Medical Center
mi
from
Olympia, WA
Paclitaxel in Treating Patients With Ovarian Stromal Cancer
Phase II Study of Paclitaxel for Ovarian Stromal Tumors as Second-Line Therapy
Status: Enrolling
Updated: 8/23/2017
Capital Medical Center
mi
from
Olympia, WA
Click here to add this to my saved trials
Paclitaxel in Treating Patients With Ovarian Stromal Cancer
Phase II Study of Paclitaxel for Ovarian Stromal Tumors as Second-Line Therapy
Status: Enrolling
Updated:  8/23/2017
MultiCare Good Samaritan Hospital
mi
from
Puyallup, WA
Paclitaxel in Treating Patients With Ovarian Stromal Cancer
Phase II Study of Paclitaxel for Ovarian Stromal Tumors as Second-Line Therapy
Status: Enrolling
Updated: 8/23/2017
MultiCare Good Samaritan Hospital
mi
from
Puyallup, WA
Click here to add this to my saved trials
Paclitaxel in Treating Patients With Ovarian Stromal Cancer
Phase II Study of Paclitaxel for Ovarian Stromal Tumors as Second-Line Therapy
Status: Enrolling
Updated:  8/23/2017
MultiCare Allenmore Hospital
mi
from
Tacoma, WA
Paclitaxel in Treating Patients With Ovarian Stromal Cancer
Phase II Study of Paclitaxel for Ovarian Stromal Tumors as Second-Line Therapy
Status: Enrolling
Updated: 8/23/2017
MultiCare Allenmore Hospital
mi
from
Tacoma, WA
Click here to add this to my saved trials
Paclitaxel in Treating Patients With Ovarian Stromal Cancer
Phase II Study of Paclitaxel for Ovarian Stromal Tumors as Second-Line Therapy
Status: Enrolling
Updated:  8/23/2017
Northwest NCI Community Oncology Research Program
mi
from
Tacoma, WA
Paclitaxel in Treating Patients With Ovarian Stromal Cancer
Phase II Study of Paclitaxel for Ovarian Stromal Tumors as Second-Line Therapy
Status: Enrolling
Updated: 8/23/2017
Northwest NCI Community Oncology Research Program
mi
from
Tacoma, WA
Click here to add this to my saved trials
Paclitaxel in Treating Patients With Ovarian Stromal Cancer
Phase II Study of Paclitaxel for Ovarian Stromal Tumors as Second-Line Therapy
Status: Enrolling
Updated:  8/23/2017
West Virginia University Healthcare
mi
from
Morgantown, WV
Paclitaxel in Treating Patients With Ovarian Stromal Cancer
Phase II Study of Paclitaxel for Ovarian Stromal Tumors as Second-Line Therapy
Status: Enrolling
Updated: 8/23/2017
West Virginia University Healthcare
mi
from
Morgantown, WV
Click here to add this to my saved trials
Paclitaxel in Treating Patients With Ovarian Stromal Cancer
Phase II Study of Paclitaxel for Ovarian Stromal Tumors as Second-Line Therapy
Status: Enrolling
Updated:  8/23/2017
Tohoku University School of Medicine
mi
from
Sendai,
Paclitaxel in Treating Patients With Ovarian Stromal Cancer
Phase II Study of Paclitaxel for Ovarian Stromal Tumors as Second-Line Therapy
Status: Enrolling
Updated: 8/23/2017
Tohoku University School of Medicine
mi
from
Sendai,
Click here to add this to my saved trials
Paclitaxel in Treating Patients With Ovarian Stromal Cancer
Phase II Study of Paclitaxel for Ovarian Stromal Tumors as Second-Line Therapy
Status: Enrolling
Updated:  8/23/2017
Banner Thunderbird Medical Center
mi
from
Glendale, AZ
Paclitaxel in Treating Patients With Ovarian Stromal Cancer
Phase II Study of Paclitaxel for Ovarian Stromal Tumors as Second-Line Therapy
Status: Enrolling
Updated: 8/23/2017
Banner Thunderbird Medical Center
mi
from
Glendale, AZ
Click here to add this to my saved trials
Paclitaxel in Treating Patients With Ovarian Stromal Cancer
Phase II Study of Paclitaxel for Ovarian Stromal Tumors as Second-Line Therapy
Status: Enrolling
Updated:  8/23/2017
Banner - University Medical Center Phoenix
mi
from
Phoenix, AZ
Paclitaxel in Treating Patients With Ovarian Stromal Cancer
Phase II Study of Paclitaxel for Ovarian Stromal Tumors as Second-Line Therapy
Status: Enrolling
Updated: 8/23/2017
Banner - University Medical Center Phoenix
mi
from
Phoenix, AZ
Click here to add this to my saved trials
Paclitaxel in Treating Patients With Ovarian Stromal Cancer
Phase II Study of Paclitaxel for Ovarian Stromal Tumors as Second-Line Therapy
Status: Enrolling
Updated:  8/23/2017
Union Hospital of Cecil County
mi
from
Elkton, MD
Paclitaxel in Treating Patients With Ovarian Stromal Cancer
Phase II Study of Paclitaxel for Ovarian Stromal Tumors as Second-Line Therapy
Status: Enrolling
Updated: 8/23/2017
Union Hospital of Cecil County
mi
from
Elkton, MD
Click here to add this to my saved trials
Paclitaxel in Treating Patients With Ovarian Stromal Cancer
Phase II Study of Paclitaxel for Ovarian Stromal Tumors as Second-Line Therapy
Status: Enrolling
Updated:  8/23/2017
Keesler Medical Center
mi
from
Biloxi, MS
Paclitaxel in Treating Patients With Ovarian Stromal Cancer
Phase II Study of Paclitaxel for Ovarian Stromal Tumors as Second-Line Therapy
Status: Enrolling
Updated: 8/23/2017
Keesler Medical Center
mi
from
Biloxi, MS
Click here to add this to my saved trials
Paclitaxel in Treating Patients With Ovarian Stromal Cancer
Phase II Study of Paclitaxel for Ovarian Stromal Tumors as Second-Line Therapy
Status: Enrolling
Updated:  8/23/2017
Jersey Shore Medical Center
mi
from
Neptune City, NJ
Paclitaxel in Treating Patients With Ovarian Stromal Cancer
Phase II Study of Paclitaxel for Ovarian Stromal Tumors as Second-Line Therapy
Status: Enrolling
Updated: 8/23/2017
Jersey Shore Medical Center
mi
from
Neptune City, NJ
Click here to add this to my saved trials
Paclitaxel in Treating Patients With Ovarian Stromal Cancer
Phase II Study of Paclitaxel for Ovarian Stromal Tumors as Second-Line Therapy
Status: Enrolling
Updated:  8/23/2017
Montefiore Medical Center-Einstein Campus
mi
from
The Bronx, NY
Paclitaxel in Treating Patients With Ovarian Stromal Cancer
Phase II Study of Paclitaxel for Ovarian Stromal Tumors as Second-Line Therapy
Status: Enrolling
Updated: 8/23/2017
Montefiore Medical Center-Einstein Campus
mi
from
The Bronx, NY
Click here to add this to my saved trials
Paclitaxel in Treating Patients With Ovarian Stromal Cancer
Phase II Study of Paclitaxel for Ovarian Stromal Tumors as Second-Line Therapy
Status: Enrolling
Updated:  8/23/2017
Montefiore Medical Center - Moses Campus
mi
from
The Bronx, NY
Paclitaxel in Treating Patients With Ovarian Stromal Cancer
Phase II Study of Paclitaxel for Ovarian Stromal Tumors as Second-Line Therapy
Status: Enrolling
Updated: 8/23/2017
Montefiore Medical Center - Moses Campus
mi
from
The Bronx, NY
Click here to add this to my saved trials
Paclitaxel in Treating Patients With Ovarian Stromal Cancer
Phase II Study of Paclitaxel for Ovarian Stromal Tumors as Second-Line Therapy
Status: Enrolling
Updated:  8/23/2017
University of Cincinnati/Barrett Cancer Center
mi
from
Cincinnati, OH
Paclitaxel in Treating Patients With Ovarian Stromal Cancer
Phase II Study of Paclitaxel for Ovarian Stromal Tumors as Second-Line Therapy
Status: Enrolling
Updated: 8/23/2017
University of Cincinnati/Barrett Cancer Center
mi
from
Cincinnati, OH
Click here to add this to my saved trials
Paclitaxel in Treating Patients With Ovarian Stromal Cancer
Phase II Study of Paclitaxel for Ovarian Stromal Tumors as Second-Line Therapy
Status: Enrolling
Updated:  8/23/2017
Penn State Milton S. Hershey Medical Center
mi
from
Hershey, PA
Paclitaxel in Treating Patients With Ovarian Stromal Cancer
Phase II Study of Paclitaxel for Ovarian Stromal Tumors as Second-Line Therapy
Status: Enrolling
Updated: 8/23/2017
Penn State Milton S. Hershey Medical Center
mi
from
Hershey, PA
Click here to add this to my saved trials
Paclitaxel in Treating Patients With Ovarian Stromal Cancer
Phase II Study of Paclitaxel for Ovarian Stromal Tumors as Second-Line Therapy
Status: Enrolling
Updated:  8/23/2017
Wilford Hall Medical Center
mi
from
Lackland Air Force Base, TX
Paclitaxel in Treating Patients With Ovarian Stromal Cancer
Phase II Study of Paclitaxel for Ovarian Stromal Tumors as Second-Line Therapy
Status: Enrolling
Updated: 8/23/2017
Wilford Hall Medical Center
mi
from
Lackland Air Force Base, TX
Click here to add this to my saved trials
Intraperitoneal Paclitaxel, Doxorubicin Hydrochloride, and Cisplatin in Treating Patients With Stage III-IV Endometrial Cancer
A Phase I Study of IV Doxorubicin Plus Intraperitoneal (IP) Paclitaxel and IV or IP Cisplatin in Endometrial Cancer Patients at High Risk for Peritoneal Failure
Status: Enrolling
Updated:  8/23/2017
The Hartford Hospital
mi
from
Hartford, CT
Intraperitoneal Paclitaxel, Doxorubicin Hydrochloride, and Cisplatin in Treating Patients With Stage III-IV Endometrial Cancer
A Phase I Study of IV Doxorubicin Plus Intraperitoneal (IP) Paclitaxel and IV or IP Cisplatin in Endometrial Cancer Patients at High Risk for Peritoneal Failure
Status: Enrolling
Updated: 8/23/2017
The Hartford Hospital
mi
from
Hartford, CT
Click here to add this to my saved trials